Source:http://linkedlifedata.com/resource/pubmed/id/16113962
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
2005-8-22
|
| pubmed:abstractText |
This review of second-generation H1-receptor antagonists aims to examine the therapeutic index of the different drugs that are available in light of the new criteria linked to specific and non-specific pharmacological activities.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1369-7056
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
2
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1295-301
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
H1-receptor antagonists: a critical reappraisal.
|
| pubmed:affiliation |
UCB Pharma, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium.
|
| pubmed:publicationType |
Journal Article
|